Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany. Real-world evidence from Germany
- Winfried März
- , Franz-Werner Dippel
- , Karlheinz Theobald
- , Katherine Gorcyca
- , Serban R Iorga
- , David Ansell
Research output: Contribution to journal › Article › peer-review
24
Citations
(Scopus)
267
Downloads
(Pure)